ZBH
Zimmer Biomet Holdings, Inc.
Price Chart
Latest Quote
$87.33
+0.64 (+0.74%)
Current Price
| Previous Close | $86.69 |
| Open | $87.60 |
| Day High | $88.67 |
| Day Low | $86.53 |
| Volume | 1,411,152 |
Stock Information
| Quarterly Dividend / Yield | $0.96 / 1.10% |
| Shares Outstanding | 193.46M |
| Quarterly Dividend Yield | 1.10% |
| Quarterly Dividend | $0.96 |
| Total Debt | $7.59B |
| Cash Equivalents | $478.50M |
| Revenue | $8.41B |
| Net Income | $761.20M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $16.90B |
| P/E Ratio | 22.62 |
| EPS (TTM) | $3.86 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $24.01B |
| Sales | $8.41B |
| Income | $761.20M |
| Book/sh | $65.53 |
| Cash/sh | $2.47 |
| Employees | 17K |
Financial Ratios
| Quick Ratio | 0.77 |
| Current Ratio | 1.73 |
| Debt/Eq | 59.83 |
| EPS Growth TTM | 30.80% |
Returns & Margins
| ROA | 4.10% |
| ROE | 6.07% |
| Gross Margin | 70.18% |
| Operating Margin | 19.69% |
| Profit Margin | 9.05% |
Ownership
| Insider Ownership | 0.20% |
| Institutional Ownership | 106.53% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 9.70 |
| PEG | 0.60 |
| P/S | 2.01 |
| P/B | 1.33 |
Analyst Data
| Recommendation | hold |
| Target Price | $98.70 |
Technical Indicators
| SMA20 | $83.98 |
| SMA50 | $87.45 |
| SMA200 | $92.98 |
| RSI | 65.09 |
| ATR | 2.3150 |
| Shares Float | 192.93M |
| Short Float | 6.22% |
| Short Ratio | 3.46 |
| Volatility | 0.47 |
| Rel Volume | 0.63 |
Performance History
| Week | +6.07% |
| Month | +5.43% |
| Quarter | -6.95% |
| 6 Months | -5.69% |
| YTD | -2.72% |
| Year | -3.52% |
| 3 Years | -29.55% |
| 5 Years | -44.27% |
| 10 Years | -19.69% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $87.33 | 1,411,152 |
| 2026-06-04 | $86.69 | 1,623,400 |
| 2026-06-03 | $84.98 | 1,948,400 |
| 2026-06-02 | $83.75 | 2,601,900 |
| 2026-06-01 | $82.94 | 2,704,100 |
| 2026-05-29 | $82.33 | 3,216,600 |
| 2026-05-28 | $82.82 | 2,312,900 |
| 2026-05-27 | $82.56 | 1,666,700 |
| 2026-05-26 | $84.41 | 2,072,700 |
| 2026-05-22 | $85.50 | 1,809,800 |
| 2026-05-21 | $85.31 | 1,895,400 |
| 2026-05-20 | $85.38 | 2,569,100 |
| 2026-05-19 | $86.08 | 2,918,400 |
| 2026-05-18 | $85.14 | 2,303,200 |
| 2026-05-15 | $83.70 | 2,578,900 |
| 2026-05-14 | $82.65 | 2,170,800 |
| 2026-05-13 | $82.72 | 2,239,200 |
| 2026-05-12 | $83.37 | 2,436,500 |
| 2026-05-11 | $79.58 | 2,229,600 |
| 2026-05-08 | $82.33 | 2,077,400 |
| 2026-05-07 | $83.37 | 2,177,600 |
| 2026-05-06 | $82.83 | 2,379,000 |
About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
đ° Latest News
Why Is Perrigo (PRGO) Down 9% Since Last Earnings Report?
Zacks âĸ 2026-06-05T15:30:27Z
Here's How Financial Strength Remains a Key Advantage for GMED
Zacks âĸ 2026-06-04T15:55:00Z
Should You Buy, Hold or Sell GMED Stock Amid Musculoskeletal Boom?
Zacks âĸ 2026-06-02T14:29:00Z
2 Profitable Stocks to Consider Right Now and 1 We Question
StockStory âĸ 2026-06-02T09:57:23Z
GE HealthCare (GEHC) Up 3.3% Since Last Earnings Report: Can It Continue?
Zacks âĸ 2026-05-29T15:30:06Z
Zimmer (ZBH) Up 3.1% Since Last Earnings Report: Can It Continue?
Zacks âĸ 2026-05-28T15:30:21Z
3 Healthcare Stocks That Fall Short
StockStory âĸ 2026-05-28T13:18:27Z
3 Reasons to Sell ZBH and 1 Stock to Buy Instead
StockStory âĸ 2026-05-27T15:53:24Z
Is Zimmer Biomet Holdings (ZBH) One of the Best Robotic Surgery Stocks to Buy?
Insider Monkey âĸ 2026-05-26T12:09:01Z
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
Zacks âĸ 2026-05-18T13:40:06Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $2,065,800,000 | $1,786,800,000 | $1,693,600,000 | $1,619,900,000 |
| Cost Of Revenue | $2,493,700,000 | $2,191,200,000 | $2,083,800,000 | $2,019,500,000 |
| Total Revenue | $8,231,500,000 | $7,678,600,000 | $7,394,200,000 | $6,939,900,000 |
| Operating Revenue | $8,231,500,000 | $7,678,600,000 | $7,394,200,000 | $6,939,900,000 |
| Expenses | ||||
| Interest Expense | $292,800,000 | $218,000,000 | $201,200,000 | $164,800,000 |
| Total Expenses | $6,875,300,000 | $6,150,300,000 | $5,942,900,000 | $5,747,800,000 |
| Other Income Expense | $-232,600,000 | $-273,700,000 | $-182,900,000 | $-623,800,000 |
| Other Non Operating Income Expenses | $25,500,000 | $-31,100,000 | $-9,300,000 | $-128,000,000 |
| Net Non Operating Interest Income Expense | $-292,800,000 | $-218,000,000 | $-201,200,000 | $-164,800,000 |
| Interest Expense Non Operating | $292,800,000 | $218,000,000 | $201,200,000 | $164,800,000 |
| Operating Expense | $4,381,600,000 | $3,959,100,000 | $3,859,100,000 | $3,728,300,000 |
| Other Operating Expenses | - | - | - | $33,800,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $705,100,000 | $903,800,000 | $1,024,000,000 | $290,200,000 |
| Net Interest Income | $-292,800,000 | $-218,000,000 | $-201,200,000 | $-164,800,000 |
| Normalized Income | $924,149,482 | $1,115,647,887 | $1,190,656,000 | $647,671,800 |
| Net Income From Continuing And Discontinued Operation | $705,100,000 | $903,800,000 | $1,024,000,000 | $231,400,000 |
| Total Operating Income As Reported | $1,098,100,000 | $1,285,700,000 | $1,277,700,000 | $696,300,000 |
| Net Income Common Stockholders | $705,100,000 | $903,800,000 | $1,024,000,000 | $231,400,000 |
| Net Income | $705,100,000 | $903,800,000 | $1,024,000,000 | $231,400,000 |
| Net Income Including Noncontrolling Interests | $705,100,000 | $905,200,000 | $1,025,100,000 | $232,400,000 |
| Net Income Continuous Operations | $705,100,000 | $905,200,000 | $1,025,100,000 | $291,200,000 |
| Pretax Income | $830,800,000 | $1,036,600,000 | $1,067,300,000 | $403,500,000 |
| Special Income Charges | $-258,100,000 | $-242,600,000 | $-173,600,000 | $-495,800,000 |
| Operating Income | $1,356,200,000 | $1,528,300,000 | $1,451,300,000 | $1,192,100,000 |
| Depreciation Amortization Depletion Income Statement | $665,900,000 | $591,900,000 | $561,500,000 | $526,800,000 |
| Depreciation And Amortization In Income Statement | $665,900,000 | $591,900,000 | $561,500,000 | $526,800,000 |
| Amortization Of Intangibles Income Statement | $665,900,000 | $591,900,000 | $561,500,000 | $526,800,000 |
| Gross Profit | $5,737,800,000 | $5,487,400,000 | $5,310,400,000 | $4,920,400,000 |
| Net Income Discontinuous Operations | - | $0 | $0 | $-58,800,000 |
| Per Share | ||||
| Diluted EPS | $3.55 | $4.43 | $4.88 | $1.10 |
| Basic EPS | $3.56 | $4.45 | $4.91 | $1.10 |
| Other | ||||
| Tax Effect Of Unusual Items | $-39,050,518 | $-30,752,113 | $-6,944,000 | $-138,328,200 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $2,475,500,000 | $2,493,500,000 | $2,393,800,000 | $1,990,500,000 |
| Total Unusual Items | $-258,100,000 | $-242,600,000 | $-173,600,000 | $-495,800,000 |
| Total Unusual Items Excluding Goodwill | $-258,100,000 | $-242,600,000 | $-173,600,000 | $-495,800,000 |
| Reconciled Depreciation | $1,093,800,000 | $996,300,000 | $951,700,000 | $926,400,000 |
| EBITDA (Bullshit earnings) | $2,217,400,000 | $2,250,900,000 | $2,220,200,000 | $1,494,700,000 |
| EBIT | $1,123,600,000 | $1,254,600,000 | $1,268,500,000 | $568,300,000 |
| Diluted Average Shares | $198,700,000 | $203,900,000 | $209,700,000 | $210,300,000 |
| Basic Average Shares | $198,000,000 | $203,100,000 | $208,700,000 | $209,600,000 |
| Diluted NI Availto Com Stockholders | $705,100,000 | $903,800,000 | $1,024,000,000 | $231,400,000 |
| Minority Interests | $100,000 | $-1,500,000 | $-1,100,000 | $-1,000,000 |
| Tax Provision | $125,700,000 | $131,400,000 | $42,200,000 | $112,300,000 |
| Restructuring And Mergern Acquisition | $258,100,000 | $242,600,000 | $173,600,000 | $203,000,000 |
| Amortization | $665,900,000 | $591,900,000 | $561,500,000 | $526,800,000 |
| Research And Development | $458,500,000 | $437,400,000 | $458,700,000 | $406,000,000 |
| Selling General And Administration | $3,257,200,000 | $2,929,800,000 | $2,838,900,000 | $2,761,700,000 |
| Impairment Of Capital Assets | - | $0 | $0 | $292,800,000 |
| Other Special Charges | - | - | - | - |
Fetched: 2026-06-02
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-1,966,700,000 | $-1,081,400,000 | $-1,194,400,000 | $-1,623,700,000 |
| Total Assets | $23,091,700,000 | $21,365,300,000 | $21,496,900,000 | $21,066,000,000 |
| Total Non Current Assets | $17,971,800,000 | $16,693,800,000 | $16,887,400,000 | $16,638,700,000 |
| Other Non Current Assets | $1,100,300,000 | $1,095,500,000 | $1,152,100,000 | $1,122,200,000 |
| Goodwill And Other Intangible Assets | $14,664,400,000 | $13,549,500,000 | $13,674,900,000 | $13,644,000,000 |
| Other Intangible Assets | $4,717,300,000 | $4,598,400,000 | $4,856,400,000 | $5,063,800,000 |
| Current Assets | $5,119,900,000 | $4,671,500,000 | $4,609,500,000 | $4,427,300,000 |
| Other Current Assets | $537,200,000 | $430,000,000 | $366,100,000 | $522,900,000 |
| Inventory | $2,286,400,000 | $2,235,300,000 | $2,385,200,000 | $2,147,200,000 |
| Receivables | $1,704,400,000 | $1,480,700,000 | $1,442,400,000 | $1,381,500,000 |
| Accounts Receivable | $1,704,400,000 | $1,480,700,000 | $1,442,400,000 | $1,381,500,000 |
| Allowance For Doubtful Accounts Receivable | $-109,800,000 | $-93,200,000 | $-75,100,000 | $-78,400,000 |
| Gross Accounts Receivable | $1,814,200,000 | $1,573,900,000 | $1,517,500,000 | $1,459,900,000 |
| Cash Cash Equivalents And Short Term Investments | $591,900,000 | $525,500,000 | $415,800,000 | $375,700,000 |
| Cash And Cash Equivalents | $591,900,000 | $525,500,000 | $415,800,000 | $375,700,000 |
| Assets Held For Sale Current | - | - | - | $0 |
| Prepaid Assets | - | - | - | $198,400,000 |
| Debt | ||||
| Net Debt | $6,927,200,000 | $5,679,100,000 | $5,352,100,000 | $5,320,800,000 |
| Total Debt | $7,519,100,000 | $6,204,600,000 | $5,767,900,000 | $5,696,500,000 |
| Long Term Debt And Capital Lease Obligation | $6,932,000,000 | $5,341,600,000 | $4,867,900,000 | $5,152,200,000 |
| Long Term Debt | $6,932,000,000 | $5,341,600,000 | $4,867,900,000 | $5,152,200,000 |
| Current Debt And Capital Lease Obligation | $587,100,000 | $863,000,000 | $900,000,000 | $544,300,000 |
| Current Debt | $587,100,000 | $863,000,000 | $900,000,000 | $544,300,000 |
| Other Current Borrowings | $587,100,000 | $863,000,000 | $900,000,000 | $544,300,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $10,385,900,000 | $8,889,100,000 | $9,008,800,000 | $9,039,000,000 |
| Total Non Current Liabilities Net Minority Interest | $7,802,200,000 | $6,438,200,000 | $6,151,400,000 | $6,680,800,000 |
| Other Non Current Liabilities | $626,100,000 | $744,100,000 | $925,900,000 | $632,600,000 |
| Non Current Deferred Liabilities | $244,100,000 | $352,500,000 | $357,600,000 | $474,800,000 |
| Non Current Deferred Taxes Liabilities | $244,100,000 | $352,500,000 | $357,600,000 | $474,800,000 |
| Current Liabilities | $2,583,700,000 | $2,450,900,000 | $2,857,400,000 | $2,358,200,000 |
| Other Current Liabilities | $382,000,000 | $313,600,000 | $326,100,000 | $502,800,000 |
| Payables And Accrued Expenses | $1,614,600,000 | $1,274,300,000 | $1,631,300,000 | $1,311,100,000 |
| Payables | $303,000,000 | $194,600,000 | $410,600,000 | $392,600,000 |
| Accounts Payable | $303,000,000 | $194,600,000 | $410,600,000 | $354,100,000 |
| Derivative Product Liabilities | - | - | $-144,700,000 | $-172,000,000 |
| Tradeand Other Payables Non Current | - | - | $273,700,000 | $421,200,000 |
| Total Tax Payable | - | - | $61,200,000 | $38,500,000 |
| Income Tax Payable | - | - | $61,200,000 | $38,500,000 |
| Liabilities Heldfor Sale Non Current | - | - | - | $0 |
| Current Deferred Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $12,697,700,000 | $12,468,100,000 | $12,480,500,000 | $12,020,300,000 |
| Total Equity Gross Minority Interest | $12,705,800,000 | $12,476,200,000 | $12,488,100,000 | $12,027,000,000 |
| Stockholders Equity | $12,697,700,000 | $12,468,100,000 | $12,480,500,000 | $12,020,300,000 |
| Gains Losses Not Affecting Retained Earnings | $-205,700,000 | $-262,800,000 | $-191,000,000 | $-179,300,000 |
| Other Equity Adjustments | $-205,700,000 | $-262,800,000 | $-191,000,000 | $-179,300,000 |
| Retained Earnings | $11,611,000,000 | $11,095,300,000 | $10,384,500,000 | $9,559,300,000 |
| Other | ||||
| Treasury Shares Number | $123,200,000 | $118,400,000 | $110,600,000 | $104,800,000 |
| Ordinary Shares Number | $195,481,555 | $199,073,712 | $205,600,000 | $209,000,000 |
| Share Issued | $318,681,555 | $317,473,712 | $316,200,000 | $313,800,000 |
| Tangible Book Value | $-1,966,700,000 | $-1,081,400,000 | $-1,194,400,000 | $-1,623,700,000 |
| Invested Capital | $20,216,800,000 | $18,672,700,000 | $18,248,400,000 | $17,716,800,000 |
| Working Capital | $2,536,200,000 | $2,220,600,000 | $1,752,100,000 | $2,069,100,000 |
| Total Capitalization | $19,629,700,000 | $17,809,700,000 | $17,348,400,000 | $17,172,500,000 |
| Minority Interest | $8,100,000 | $8,100,000 | $7,700,000 | $6,700,000 |
| Treasury Stock | $8,889,400,000 | $8,405,700,000 | $7,562,300,000 | $6,867,200,000 |
| Additional Paid In Capital | $10,178,600,000 | $10,038,100,000 | $9,846,100,000 | $9,504,400,000 |
| Capital Stock | $3,200,000 | $3,200,000 | $3,200,000 | $3,100,000 |
| Common Stock | $3,200,000 | $3,200,000 | $3,200,000 | $3,100,000 |
| Current Accrued Expenses | $1,311,600,000 | $1,079,700,000 | $1,220,700,000 | $918,500,000 |
| Goodwill | $9,947,100,000 | $8,951,100,000 | $8,818,500,000 | $8,580,200,000 |
| Net PPE | $2,207,100,000 | $2,048,800,000 | $2,060,400,000 | $1,872,500,000 |
| Accumulated Depreciation | $-5,050,300,000 | $-4,641,400,000 | $-4,705,800,000 | $-4,585,900,000 |
| Gross PPE | $7,257,400,000 | $6,690,200,000 | $6,766,200,000 | $6,458,400,000 |
| Construction In Progress | $286,300,000 | $233,900,000 | $200,600,000 | $144,100,000 |
| Other Properties | $3,905,000,000 | $3,589,600,000 | $3,748,600,000 | $3,683,500,000 |
| Machinery Furniture Equipment | $623,800,000 | $575,100,000 | $552,200,000 | $518,200,000 |
| Buildings And Improvements | $2,419,800,000 | $2,273,100,000 | $2,245,900,000 | $2,093,400,000 |
| Land And Improvements | $22,500,000 | $18,500,000 | $18,900,000 | $19,200,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $1,832,200,000 | $1,771,700,000 | $1,831,200,000 | $1,655,000,000 |
| Work In Process | $181,000,000 | $175,100,000 | $246,500,000 | $230,900,000 |
| Raw Materials | $273,200,000 | $288,500,000 | $307,500,000 | $261,300,000 |
| Pensionand Other Post Retirement Benefit Plans Current | - | - | $417,100,000 | $336,200,000 |
| Current Deferred Revenue | - | - | - | - |
Fetched: 2026-06-02
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $1,420,200,000 | $1,142,600,000 | $1,187,100,000 | $1,067,100,000 |
| Operating Activities | ||||
| Operating Cash Flow | $1,697,100,000 | $1,499,400,000 | $1,581,600,000 | $1,284,700,000 |
| Cash Flow From Continuing Operating Activities | $1,697,100,000 | $1,499,400,000 | $1,581,600,000 | $1,356,200,000 |
| Cash From Discontinued Operating Activities | - | $0 | $0 | $-71,500,000 |
| Operating Gains Losses | - | - | $-2,500,000 | $116,600,000 |
| Investing Activities | ||||
| Capital Expenditure | $-276,900,000 | $-356,800,000 | $-394,500,000 | $-217,600,000 |
| Investing Cash Flow | $-1,975,700,000 | $-888,100,000 | $-778,900,000 | $-529,200,000 |
| Cash Flow From Continuing Investing Activities | $-1,975,700,000 | $-888,100,000 | $-778,900,000 | $-522,000,000 |
| Net Other Investing Changes | $-4,700,000 | $-36,800,000 | $28,800,000 | $-35,700,000 |
| Cash From Discontinued Investing Activities | - | $0 | $0 | $-7,200,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-487,000,000 | $-868,000,000 | $-692,200,000 | $-126,400,000 |
| Financing Cash Flow | $326,000,000 | $-484,500,000 | $-763,500,000 | $-843,800,000 |
| Cash Flow From Continuing Financing Activities | $326,000,000 | $-484,500,000 | $-763,500,000 | $-775,700,000 |
| Net Other Financing Charges | $-65,500,000 | $-38,900,000 | $-26,100,000 | $534,500,000 |
| Cash Dividends Paid | $-190,300,000 | $-196,000,000 | $-200,900,000 | $-201,200,000 |
| Common Stock Dividend Paid | $-190,300,000 | $-196,000,000 | $-200,900,000 | $-201,200,000 |
| Net Common Stock Issuance | $-487,000,000 | $-868,000,000 | $-692,200,000 | $-126,400,000 |
| Cash From Discontinued Financing Activities | - | $0 | $0 | $-68,100,000 |
| Other | ||||
| Repayment Of Debt | $-1,463,000,000 | $-900,000,000 | $-445,200,000 | $-1,518,700,000 |
| Issuance Of Debt | $2,492,100,000 | $1,436,300,000 | $499,800,000 | $83,000,000 |
| End Cash Position | $591,900,000 | $525,500,000 | $415,800,000 | $375,700,000 |
| Beginning Cash Position | $525,500,000 | $415,800,000 | $375,700,000 | $478,500,000 |
| Effect Of Exchange Rate Changes | $19,000,000 | $-17,100,000 | $900,000 | $-14,500,000 |
| Changes In Cash | $47,400,000 | $126,800,000 | $39,200,000 | $-88,300,000 |
| Proceeds From Stock Option Exercised | $39,700,000 | $82,100,000 | $101,100,000 | $78,100,000 |
| Common Stock Payments | $-487,000,000 | $-868,000,000 | $-692,200,000 | $-126,400,000 |
| Net Issuance Payments Of Debt | $1,029,100,000 | $536,300,000 | $54,600,000 | $-1,060,700,000 |
| Net Long Term Debt Issuance | $1,029,100,000 | $536,300,000 | $54,600,000 | $-1,435,700,000 |
| Long Term Debt Payments | $-1,463,000,000 | $-900,000,000 | $-445,200,000 | $-1,518,700,000 |
| Long Term Debt Issuance | $2,492,100,000 | $1,436,300,000 | $499,800,000 | $83,000,000 |
| Net Investment Purchase And Sale | $-300,900,000 | $-218,200,000 | $-278,300,000 | $-168,900,000 |
| Purchase Of Investment | $-300,900,000 | $-240,300,000 | $-311,700,000 | $-258,300,000 |
| Net Business Purchase And Sale | $-1,393,200,000 | $-276,300,000 | $-134,900,000 | $-99,800,000 |
| Purchase Of Business | $-1,393,200,000 | $-276,300,000 | $-134,900,000 | $-99,800,000 |
| Net Intangibles Purchase And Sale | $-52,400,000 | $-153,000,000 | $-103,400,000 | $-29,700,000 |
| Purchase Of Intangibles | $-52,400,000 | $-153,000,000 | $-103,400,000 | $-29,700,000 |
| Net PPE Purchase And Sale | $-224,500,000 | $-203,800,000 | $-291,100,000 | $-187,900,000 |
| Purchase Of PPE | $-224,500,000 | $-203,800,000 | $-291,100,000 | $-187,900,000 |
| Change In Working Capital | $-104,900,000 | $-455,400,000 | $-398,700,000 | $-311,400,000 |
| Change In Other Working Capital | $-177,600,000 | $-93,600,000 | $-51,100,000 | $-154,100,000 |
| Change In Payables And Accrued Expense | $101,800,000 | $-322,000,000 | $-55,300,000 | $103,000,000 |
| Change In Inventory | $98,200,000 | $49,900,000 | $-240,400,000 | $-75,600,000 |
| Change In Receivables | $-127,300,000 | $-89,700,000 | $-51,900,000 | $-184,700,000 |
| Other Non Cash Items | $100,000 | - | - | - |
| Stock Based Compensation | $90,200,000 | $101,000,000 | $99,800,000 | $105,000,000 |
| Deferred Tax | $-87,200,000 | $-47,700,000 | $-96,300,000 | $-64,400,000 |
| Deferred Income Tax | $-87,200,000 | $-47,700,000 | $-96,300,000 | $-64,400,000 |
| Depreciation Amortization Depletion | $1,093,800,000 | $996,300,000 | $951,700,000 | $926,400,000 |
| Depreciation And Amortization | $1,093,800,000 | $996,300,000 | $951,700,000 | $926,400,000 |
| Net Income From Continuing Operations | $705,100,000 | $905,200,000 | $1,025,100,000 | $291,200,000 |
| Net Short Term Debt Issuance | - | $-50,000,000 | $-325,000,000 | $375,000,000 |
| Sale Of Investment | - | $22,100,000 | $33,400,000 | $89,400,000 |
| Asset Impairment Charge | - | $0 | $0 | $292,800,000 |
| Gain Loss On Sale Of Business | - | $0 | $-2,500,000 | $116,600,000 |
| Gain Loss On Investment Securities | - | - | - | $116,600,000 |
Fetched: 2026-06-02